Hedge Fund Industry News
A collection of Hedge Fund latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Hedge Funds Eye Exotic Options to Play Huge Cross-Asset Swings
The wild swings led by oil since the start of the Iran war have institutional investors turning to exotic hybrid options to trade cross-market gyrations. Oil prices swung almost $36 a barrel on March 9, the biggest one-day range on record…
Hedge Fund Boone Capital Initiated a Stake in HealthEquity. Is the Stock a Buy?
According to a U.S. Securities and Exchange Commission (SEC) filing dated February 17, 2026, Boone Capital Management established a new position in HealthEquity by purchasing 212,856 shares. The reported value of the transaction was $19,499,738, as…
A Healthcare Hedge Fund Just Added $24.5 Million in Immunovant Stock. Should you?
On February 17, 2026, Logos Global Management LP disclosed in a Securities and Exchange Commission filing that it bought 1,100,000 shares of Immunovant (IMVT 2.32%), an estimated $24.53 million trade based on quarterly average pricing. Logos bought…
Hedge fund Palliser says Korean investors starting to embrace shareholder activism
SEOUL, March 16: London-based hedge fund Palliser Capital said South Korea is becoming more receptive to foreign shareholder activism, with local investors joining more efforts to challenge how family-controlled conglomerates do business. Palliser…
Telecom Stock Up 25% Over the Past Year Draws $21 Million Bet From Hedge Fund
Kerrisdale Advisers initiated a new position in Telephone and Data Systems (TDS 0.78%), acquiring 506,067 shares in the fourth quarter, valued at $20.75 million based on quarter-end pricing, according to a February 17, 2026, SEC filing. According…
Thames Water lenders float new £10bn rescue plan
Thames Water's lenders have put forward a £10bn rescue plan that would involve paying off the troubled water company's hundreds of millions of pounds-worth of fines for leaks and pollution, as part of an effort to stave off financial…
Thermo Fisher Scientific Inc. (TMO) Positioned for Robust Growth on AI Integration and Acquisition Boost
Thermo Fisher Scientific Inc. (NYSE: TMO) is one of Goldman Sachs top healthcare stocks. On March 3 at the 47th Annual Raymond James Institutional Investor Conference, CEO Marc Casper outlined a strong strategic outlook for Thermo Fisher Scientific…
Nancy Pelosi makes shock appearance at Oscars after party with husband
Former House Speaker Nancy Pelosi shocked Hollywood's most glamorous night when she appeared on the red carpet at the star-studded Vanity Fair Oscars after party. Her appearance prompted a wave of baffled reactions online from viewers wondering why…
Is Pfizer Inc. (PFE) One of Goldman Sachs Top Healthcare Stocks?
Pfizer Inc. (NYSE: PFE) is one of Goldman Sachs top healthcare stocks. On March 9, analysts at BMO reiterated an Outperform rating on Pfizer Inc. (NYSE:PFE) and a $30 price target. The bullish stance follows positive phase 2 data on the company's…
Abbott Laboratories (ABT) Unveils XIENCE Skypoint to Advance Cardiovascular Treatment in India
Abbott Laboratories (NYSE: ABT) is one of Goldman Sachs top healthcare stocks. On March 10, Abbott Laboratories (NYSE:ABT) confirmed the launch of its most advanced generation stent, XIENCE Skypoint, in India. The launch is designed to equip…
Is Boston Scientific Corp. (BSX) Pull Back Overdone as Financial Results Impress?
Boston Scientific Corp (NYSE: BSX) is one of Goldman Sachs top healthcare stocks. On March 4, TD Cowen reiterated that Boston Scientific Corp (NYSE:BSX) stock's year-to-date decline appears overdone in the market. The stance follows a fireside chat…
This is What Merck & Co. (MRK) is Doing to Mitigate Against KEYTRUDA Exclusivity Loss
Merck & Co., Inc. (NYSE: MRK) is one of Goldman Sachs top healthcare stocks. On March 3 at the TD Cowen 46th Annual Health Care Conference, Merck & Co., Inc. (NYSE:MRK) unveiled strategic initiatives to mitigate the loss of exclusivity of its…
Gilead Sciences, Inc. (GILD): Growth Prospects Backed by Analyst Upgrades
Gilead Sciences Inc. (NASDAQ: GILD) is one of Goldman Sachs top healthcare stocks. On March 10, Jefferies initiated coverage of Gilead Sciences Inc. (NASDAQ:GILD) with a Buy rating and a $180 price target. The research firm has touted the company's…
:max_bytes(150000):strip_icc()/What-Is-a-Stock-Exchange-56a0937a3df78cafdaa2d9be.jpg)
Bond vs. Stock Markets: Key Differences Explained
Stocks represent ownership in a company, while bonds are loans to entities. Stocks bring potential for higher returns but come with more risk. Bonds provide steady income through interest payments. Diversifying with both stocks and bonds can…
Opinion | The High Cost of 'Affordability'
With oil prices flying, you can surely hear someone screaming, “$120 to fill my Ford F-150 pickup? Who's to blame?” The answer is government, but that won't stop the affordability screechers from turning the volume up to 11. They have…
Receive a Daily briefing on Hedge Fund Industry News
Get Started